From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

Scientists at the Cancer Research Manchester Institute have created a new model of Lung Squamous Cell Carcinoma (LUSC), a common type of lung cancer, to study the development, activity, and ...

Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

A gene once believed to be extremely rare may actually be surprisingly common—and capable of quietly raising the risk of ...

The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

At 38, William Lindley was a father of three kids and passionate about his job in law enforcement. But, after months of ...

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

Learn more about supplements for lung health, including vitamins, minerals, and herbs that support breathing, reduce ...

A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...

Cancer patients may have an increased risk of developing second primary malignancies after immune checkpoint inhibitor therapy.

Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in ...